Sequenom announces launch of SensiGene Cystic Fibrosis Carrier Screening test.

Sequenom Inc announced that the company's first laboratory developed test, the SensiGene Cystic Fibrosis Carrier Screening test, has been launched. This test is available exclusively through the Sequenom Center for Molecular Medicine, a next-generation CLIA (Clinical Laboratory Improvement Amendments, 1988) molecular diagnostic laboratory and a wholly-owned subsidiary of Sequenom. This SensiGene innovative test screens for 103 mutations and five variants, including the 23 mutations recommended by the American College of Medical Genetics (ACMG). This test has been shown to identify each of the 103 mutations and five variants through genomic DNA and DNA control testing. The test offers …